Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors
作者:Scott D. Edmondson、Anthony Mastracchio、Jiafang He、Christine C. Chung、Michael J. Forrest、Scott Hofsess、Euan MacIntyre、Joseph Metzger、Naphtali O'Connor、Kajal Patel、Xinchun Tong、Michael R. Tota、Lex H.T. Van der Ploeg、Jeff P. Varnerin、Michael H. Fisher、Matthew J. Wyvratt、Ann E. Weber、Emma R. Parmee
DOI:10.1016/j.bmcl.2003.08.056
日期:2003.11
Aryldihydropyridazinones and aryldimethylpyrazolones with 2-benzyl vinylogous amide substituents have been identified as potent PDE3B subtype selective inhibitors. Dihydropyridazinone 8a (PDE3B IC50 = 0.19 nM, 3A IC50 = 1.3 nM) was selected for in vivo evaluation of lipolysis induction, metabolic rate increase, and cardiovascular effects. (C) 2003 Elsevier Ltd. All rights reserved.